Development of a tool to identify patients' preference for vitamin K antagonist or direct oral anticoagulant therapy

Seminars in Thrombosis and Hemostasis

Volumn 40, Issue 1, 2014, Pages 121-128

  Zolfaghari, Shabnam ^a   Harenberg, Job ^a   Froelich, Lutz ^a   Wehling, Martin ^a   Weiss, Christel ^a  

^a UNIVERSITY OF HEIDELBERG   (Germany)

Author keywords

adherence; anticoagulation; apixaban; atrial fibrillation; dabigatran; preference; rivaroxaban; warfarin

Indexed keywords

ANTICOAGULANT AGENT; ANTIVITAMIN K; APIXABAN; DABIGATRAN; DIRECT ORAL ANTICOAGULANT; RIVAROXABAN; UNCLASSIFIED DRUG;

ADULT; ANTICOAGULANT THERAPY; ARTICLE; DEEP VEIN THROMBOSIS; DRUG INDICATION; FEMALE; HEART ATRIUM FIBRILLATION; HEART VALVE REPLACEMENT; HUMAN; LUNG EMBOLISM; MAJOR CLINICAL STUDY; MALE; MEDICATION COMPLIANCE; MIDDLE AGED; MOTIVATION; MULTICENTER STUDY; PATIENT PREFERENCE; PILOT STUDY; PRIORITY JOURNAL; PROSPECTIVE STUDY; PSYCHOLOGICAL ASPECT; QUESTIONNAIRE; SOCIAL INTERACTION; STRUCTURED INTERVIEW;

ADMINISTRATION, ORAL; ADULT; AGED; ANTICOAGULANTS; ATRIAL FIBRILLATION; FEMALE; HEART VALVE PROSTHESIS IMPLANTATION; HUMANS; MALE; MIDDLE AGED; PRACTICE GUIDELINES AS TOPIC; PULMONARY EMBOLISM; QUESTIONNAIRES; VENOUS THROMBOSIS; VITAMIN K;

EID: 84893664958     PISSN: 00946176     EISSN: 10989064     Source Type: Journal    
DOI: 10.1055/s-0033-1361940     Document Type: Article

References (54)

1. Roskell N. S., Lip G. Y., Noack H., Clemens A., Plumb J. M. Treatments for stroke prevention in atrial fibrillation: a network meta-analysis and indirect comparisons versus dabigatran etexilate. Thromb Haemost: 2010; 104 6 1106 1115
2. Lip G. Y. Stroke in atrial fibrillation: epidemiology and thromboprophylaxis. J Thromb Haemost: 2011; 9 01 344 351
3. Falck-Ytter Y., Francis C. W., Johanson N. A., et al. American College of Chest Physicians. Prevention of VTE in orthopedic surgery patients: Antithrombotic Therapy and Prevention of Thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines. Chest: 2012; 141 (2, Suppl) e278S e325S
4. Moser M., Bode C. [Anticoagulation in atrial fibrillation: a new era has begun]. Hamostaseologie: 2012; 32 1 37 39
5. Schulman S., Beyth R. J., Kearon C., Levine M. N.; American College of Chest Physicians. Hemorrhagic complications of anticoagulant and thrombolytic treatment: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines (8th Edition). Chest: 2008; 133 (6, Suppl) 257S 298S (Pubitemid 351892969)
6. Lip G. Y., Andreotti F., Fauchier L., et al. European Heart Rhythm Association. Bleeding risk assessment and management in atrial fibrillation patients. Executive Summary of a Position Document from the European Heart Rhythm Association [EHRA], endorsed by the European Society of Cardiology [ESC] Working Group on Thrombosis. Thromb Haemost: 2011; 106 6 997 1011
7. Ansell J., Hirsh J., Hylek E., Jacobson A., Crowther M., Palareti G.; American College of Chest Physicians. Pharmacology and management of the vitamin K antagonists: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines (8th Edition). Chest: 2008; 133 (6, Suppl) 160S 198S (Pubitemid 351892967)
8. Harenberg J., Marx S., Krejczy M., Wehling M. New anticoagulants - promising and failed developments. Br J Pharmacol: 2012; 165 2 363 372
9. Ogilvie I. M., Newton N., Welner S. A., Cowell W., Lip G. Y. Underuse of oral anticoagulants in atrial fibrillation: a systematic review. Am J Med: 2010; 123 7 638 645 e4
10. Bates S. M., Greer I. A., Middeldorp S., Veenstra D. L., Prabulos A. M., Vandvik P. O.; American College of Chest Physicians. VTE, thrombophilia, antithrombotic therapy, and pregnancy: Antithrombotic Therapy and Prevention of Thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines. Chest: 2012; 141 (2, Suppl) e691S e736S
11. Hirsh J., O'Donnell M., Eikelboom J. W. Beyond unfractionated heparin and warfarin: current and future advances. Circulation: 2007; 116 5 552 560 (Pubitemid 47450264)
12. Eikelboom J. W., Weitz J. I. A replacement for warfarin: the search continues. Circulation: 2007; 116 2 131 133 (Pubitemid 47057517)
13. Devereaux P. J., Anderson D. R., Gardner M. J., et al. Differences between perspectives of physicians and patients on anticoagulation in patients with atrial fibrillation: observational study. BMJ: 2001; 323 7323 1218 1222
14. Mühlbacher A. C., Stoll M., Mahlich J., Nübling M. Patient preferences for HIV/AIDS therapy - a discrete choice experiment. Health Econ Rev: 2013; 3 1 14
15. Holbrook A., Schulman S., Witt D. M., et al. American College of Chest Physicians. Evidence-based management of anticoagulant therapy: Antithrombotic Therapy and Prevention of Thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines. Chest: 2012; 141 (2, Suppl) e152S e184S
16. Anderson J. L., Halperin J. L., Albert N. M., et al. Management of patients with atrial fibrillation (compilation of 2006 ACCF/AHA/ESC and 2011 ACCF/AHA/HRS recommendations): a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines. J Am Coll Cardiol: 2013; 61 18 1935 1944
17. Camm A. J., Lip G. Y., De Caterina R., et al. ESC Committee for Practice Guidelines-CPG; Document Reviewers. 2012 focused update of the ESC Guidelines for the management of atrial fibrillation: an update of the 2010 ESC Guidelines for the management of atrial fibrillation-developed with the special contribution of the European Heart Rhythm Association. Europace: 2012; 14 10 1385 1413
18. MacLean S., Mulla S., Akl E. A., et al. American College of Chest Physicians. Patient values and preferences in decision making for antithrombotic therapy: a systematic review: Antithrombotic Therapy and Prevention of Thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines. Chest: 2012; 141 (2, Suppl) e1S e23S
19. Moia M., Mantovani L. G., Carpenedo M., et al. Patient preferences and willingness to pay for different options of anticoagulant therapy. Intern Emerg Med: 2013; 8 3 237 243
20. Harenberg J., Marx S., Abou-Ayash N., et al. Which patients would be willing to change anticoagulation from vitamin-K antagonists to a new oral anticoagulant? Haemostaseologie: 2012; 33 1 ED10 4
21. Elewa H. F., Deremer C. E., Keller K., Gujral J., Joshua T. V. Patients satisfaction with warfarin and willingness to switch to dabigatran: a patient survey. J Thromb Thrombolysis: 2013
22. Zolfaghari S., Harenberg J., Knäble H., et al. Investigation on motivation of patients to participate in clinical studies with new oral anticoagulants. Haemostaseologie: 2013; 34 1 P5 19
23. Crawford B., Stanford R. H., Wong A. Y., Dalal A. A., Bayliss M. S. Development of a questionnaire to assess experience and preference of intranasal corticosteroids in patients with allergic rhinitis. Patient Relat Outcome Meas: 2011; 2 119 126
24. Klausmann G., Hramiak I., Qvist M., Mikkelsen K. H., Guo X. Evaluation of preference for a novel durable insulin pen with memory function among patients with diabetes and health care professionals. Patient Prefer Adherence: 2013; 7 285 292
25. Nelsen A., Gupta S., Trautner B. W., et al. Intention to adhere to HIV treatment: a patient-centred predictor of antiretroviral adherence. HIV Med: 2013; 14 8 472 480
26. Politi M. C., Wolin K. Y., Légaré F. Implementing clinical practice guidelines about health promotion and disease prevention through shared decision making. J Gen Intern Med: 2013; 28 6 838 844
27. Sudlow M., Thomson R., Kenny R. A., Rodgers H. A community survey of patients with atrial fibrillation: associated disabilities and treatment preferences. Br J Gen Pract: 1998; 48 436 1775 1778 (Pubitemid 28508442)
28. Thomson R., Parkin D., Eccles M., Sudlow M., Robinson A. Decision analysis and guidelines for anticoagulant therapy to prevent stroke in patients with atrial fibrillation. Lancet: 2000; 355 9208 956 962 (Pubitemid 30148260)
29. Protheroe J., Fahey T., Montgomery A. A., Peters T. J. The impact of patients' preferences on the treatment of atrial fibrillation: observational study of patient based decision analysis. BMJ: 2000; 320 7246 1380 1384 (Pubitemid 30261119)
30. Man-Son-Hing M., Laupacis A., O'Connor A. M., Coyle D., Berquist R., McAlister F. Patient preference-based treatment thresholds and recommendations: a comparison of decision-analytic modeling with the probability-tradeoff technique. Med Decis Making: 2000; 20 4 394 403
31. Schulman S., Crowther M. A. How I treat with anticoagulants in 2012: new and old anticoagulants, and when and how to switch. Blood: 2012; 119 13 3016 3023
32. Harenberg J., Felten M., Weiss C., Frölich L. The stability of the INR, the fear of thrombotic and bleeding complications are influenced by personality traits of patients on stable oral anticoagulant therapy. Haemostaseologie: 2010; 30 1 P02 P10
33. Franke G. H. Possibilities of computer-assisted administration of the revised Freiburg Personality Inventory. 2 experimental studies[in German]. Z Exp Psychol: 1997; 44 2 332 356
34. Forgays D. G., Forgays D. K., Spielberger C. D. Factor structure of the State-Trait Anger Expression Inventory. J Pers Assess: 1997; 69 3 497 507 (Pubitemid 28132885)
35. Fisher P. L., Durham R. C. Recovery rates in generalized anxiety disorder following psychological therapy: an analysis of clinically significant change in the STAI-T across outcome studies since 1990. Psychol Med: 1999; 29 6 1425 1434
36. Sanderson K., Andrews G. The SF-12 in the Australian population: cross-validation of item selection. Aust N Z J Public Health: 2002; 26 4 343 345
37. Verkuil B., Brosschot J. F., Thayer J. F. Capturing worry in daily life: are trait questionnaires sufficient? Behav Res Ther: 2007; 45 8 1835 1844 (Pubitemid 47049807)
38. Ware J. Jr, Kosinski M., Keller S. D. A 12-Item Short-Form Health Survey: construction of scales and preliminary tests of reliability and validity. Med Care: 1996; 34 3 220 233 (Pubitemid 126433231)
39. Svirtlih N., Pavic S., Terzic D., et al. Reduced quality of life in patients with chronic viral liver disease as assessed by SF12 questionnaire. J Gastrointestin Liver Dis: 2008; 17 4 405 409
40. Völler H., Taborski U., Dovifat C., et al. ProTime self-management yielding improvement of fluency and quality of life. Thromb Haemost: 2007; 98 4 889 895 (Pubitemid 47555084)
41. Crawford B., Stanford R. H., Wong A. Y., Dalal A. A., Bayliss M. S. Psychometric validation of the experience with allergic rhinitis nasal spray questionnaire. Patient Relat Outcome Meas: 2011; 2 127 133
42. Smetana G. W., Davis R. B., Phillips R. S. Factors that influence patient response to requests to change to a unified restrictive formulary. J Gen Intern Med: 2004; 19 12 1212 1219 (Pubitemid 40041386)
43. Mussbrugger H., Kelava A. Testtheorie und Fragebogenkonstruktion. Berlin, Heidelberg. New York, NY Springer Verlag: 2008; 409
44. Rogers M. P., Orav J., Black P. M. The use of a simple Likert scale to measure quality of life in brain tumor patients. J Neurooncol: 2001; 55 2 121 131 (Pubitemid 34065328)
45. Makowski C. T., Jennings D. L., Nemerovski C. W., Szandzik E. G., Kalus J. S. The impact of pharmacist-directed patient education and anticoagulant care coordination on patient satisfaction. Ann Pharmacother: 2013; 47 6 805 810
46. Casula M., Tragni E., Catapano A. L. Adherence to lipid-lowering treatment: the patient perspective. Patient Prefer Adherence: 2012; 6 805 814
47. Alonso-Coello P., Montori V. M., Solà I., et al. Values and preferences in oral anticoagulation in patients with atrial fibrillation, physicians' and patients' perspectives: protocol for a two-phase study. BMC Health Serv Res: 2008; 8 221
48. González-Rojas N., Giménez E., Fernández M. A., et al. Preferences for oral anticoagulant treatment in the medium and long term prevention of stroke in non valvular atrial fibrillation [in Spanish]. Rev Neurol: 2012; 55 1 11 19
49. Tversky A., Kahneman D. The framing of decisions and the psychology of choice. Science: 1981; 211 4481 453 458 (Pubitemid 11145313)
50. Bergus G. R., Levin I. P., Elstein A. S. Presenting risks and benefits to patients. J Gen Intern Med: 2002; 17 8 612 617
51. Maxwell G. L., Synan I., Hayes R. P., Clarke-Pearson D. L. Preference and compliance in postoperative thromboembolism prophylaxis among gynecologic oncology patients. Obstet Gynecol: 2002; 100 3 451 455 (Pubitemid 35246130)
52. Man-Son-Hing M., Laupacis A., O'Connor A. M., et al. A patient decision aid regarding antithrombotic therapy for stroke prevention in atrial fibrillation: a randomized controlled trial. JAMA: 1999; 282 8 737 743 (Pubitemid 29404379)
53. Draycott S., Dabbs A. Cognitive dissonance. 1: An overview of the literature and its integration into theory and practice in clinical psychology. Br J Clin Psychol: 1998; 37 Pt 3 341 353 (Pubitemid 28454301)
54. Beaton D. E., Bombardier C., Guillemin F., Ferraz M. B. Guidelines for the process of cross-cultural adaptation of self-report measures. Spine: 2000; 25 24 3186 3191 (Pubitemid 32042951)